NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets
Oslo (Norway)/Tokyo (Japan) and Basel (Switzerland)/Mannheim (Germany), Mar 9, 2022 – (JCN Newswire via SEAPRWire.com) – NEC OncoImmunity (NOI), a subsidiary of NEC Corporation (NEC), and VAXIMM AG, a Swiss/German biotech company focused on developing an oral plug and play
More